You are a senior pharmaceutical commercial & strategy analyst and data-
visualization expert.
Create a visually appealing, well-structured, and color-coded executive
dashboard for the analysis of a NEW MOLECULE.
Dashboard objectives:
- Support a clear **GO / NO-GO decision**
- Combine **strategic, commercial, technical, and market insights**
- Present insights in a **clean, modern, and professional layout**
Use tables, charts, icons, and color cues (green = positive, amber =
moderate risk, red = high risk).
--------------------------------------------------
1. EXECUTIVE SUMMARY (Top Panel)
--------------------------------------------------
- Molecule Name
- FDA approval date
- Dosage Form
- Strength(s)
- Pack Size
- Therapy Area
- ATC Code
- Indication
- One-line value proposition
- Final Recommendation: **GO / NO-GO** (with color badge)
- Key decision drivers (3–5 bullets)
--------------------------------------------------
2. MARKET OVERVIEW
--------------------------------------------------
Include a structured table covering:
- Patent Status / Exclusivity (expiry year if available)
- Reference / Originator Product
- Global Presence (key regions)
- Local Presence (target market)
- Disease Prevalence & Incidence
- Target Patient Population
--------------------------------------------------
3. MARKET OPPORTUNITY
--------------------------------------------------
- Total Addressable Market (TAM)
- Key unmet needs
- Competitive intensity
- Market growth drivers & barriers
Include a market sizing chart.
--------------------------------------------------
4. FINANCIAL FORECAST (5-YEAR)
--------------------------------------------------
Provide:
- 5-year revenue forecast (Year 1–Year 5)
- Highlight **3rd-year revenue value**
- Expected annual sales units
- CAGR
- Price assumptions
- Market share assumptions
Include:
- Value & Units sold bar chart
--------------------------------------------------
5. COMPETITIVE LANDSCAPE & FUTURE COMPETITIVENESS
--------------------------------------------------
- Key competitors (brands & generics)
- Differentiation factors
- Expected new entrants
- Long-term competitiveness outlook (Low / Medium / High)
--------------------------------------------------
6. CRITICAL SUCCESS FACTORS
--------------------------------------------------
List and rate (High / Medium / Low):
- Clinical differentiation
- Pricing strategy
- Market access & reimbursement
- Physician adoption
- Patient adherence
Use a scorecard or heatmap.
--------------------------------------------------
7. TECHNICAL FEASIBILITY
--------------------------------------------------
Assess:
- API availability
- Manufacturing complexity
- Stability & formulation risks
- Regulatory complexity
- Bioequivalence / clinical requirements
- Time to market
Provide a **Technical Risk Rating**.
--------------------------------------------------
8. RISK & MITIGATION SUMMARY
--------------------------------------------------
- Commercial risks
- Technical risks
- Regulatory risks
- Mitigation strategies
--------------------------------------------------
9. FINAL DECISION PANEL
--------------------------------------------------
- Overall Attractiveness Score (0–100)
- Risk Level Indicator
- Strategic Fit
- Final Recommendation: **GO / NO-GO**
- Clear justification (bullet points)
--------------------------------------------------
DESIGN GUIDELINES
--------------------------------------------------
- Use a clean dashboard layout
- Professional pharma-style color palette
- Clear section headers
- Icons and visual indicators
- Executive-ready, boardroom quality output